1rtk

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
The C-terminal fragment, Bb, of factor B combines with C3b to form the, pivotal C3-convertase, C3bBb, of alternative complement pathway. Bb, consists of a von Willebrand factor type A (vWFA) domain that is, structurally similar to the I domains of integrins and a serine protease, (SP) domain that is in inactive conformation. The structure of the C3bBb, complex would be important in deciphering the activation mechanism of the, SP domain. However, C3bBb is labile and not amenable to X-ray diffraction, studies. We engineered a disulfide bond in the vWFA domain of Bb, homologous to that shown to lock I domains in active conformation. The, crystal structures of Bb(C428-C435) and its inhibitor complexes reveal, that the adoption of the "active" conformation by the vWFA domain is not, sufficient to activate the C3-convertase catalytic apparatus and also, provide insights into the possible mode of C3-convertase activation.
+
The C-terminal fragment, Bb, of factor B combines with C3b to form the pivotal C3-convertase, C3bBb, of alternative complement pathway. Bb consists of a von Willebrand factor type A (vWFA) domain that is structurally similar to the I domains of integrins and a serine protease (SP) domain that is in inactive conformation. The structure of the C3bBb complex would be important in deciphering the activation mechanism of the SP domain. However, C3bBb is labile and not amenable to X-ray diffraction studies. We engineered a disulfide bond in the vWFA domain of Bb homologous to that shown to lock I domains in active conformation. The crystal structures of Bb(C428-C435) and its inhibitor complexes reveal that the adoption of the "active" conformation by the vWFA domain is not sufficient to activate the C3-convertase catalytic apparatus and also provide insights into the possible mode of C3-convertase activation.
==Disease==
==Disease==
Line 19: Line 19:
[[Category: Macon, K.]]
[[Category: Macon, K.]]
[[Category: Moore, D.]]
[[Category: Moore, D.]]
-
[[Category: Narayana, S.V.]]
+
[[Category: Narayana, S V.]]
[[Category: Ponnuraj, K.]]
[[Category: Ponnuraj, K.]]
-
[[Category: Volanakis, J.E.]]
+
[[Category: Volanakis, J E.]]
[[Category: Xu, Y.]]
[[Category: Xu, Y.]]
[[Category: GBS]]
[[Category: GBS]]
Line 31: Line 31:
[[Category: factor bb-inhibitor complex]]
[[Category: factor bb-inhibitor complex]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:50:06 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:54:23 2008''

Revision as of 12:54, 21 February 2008


1rtk, resolution 2.30Å

Drag the structure with the mouse to rotate

Crystal Structure Analysis of the Bb segment of Factor B complexed with 4-guanidinobenzoic acid

Contents

Overview

The C-terminal fragment, Bb, of factor B combines with C3b to form the pivotal C3-convertase, C3bBb, of alternative complement pathway. Bb consists of a von Willebrand factor type A (vWFA) domain that is structurally similar to the I domains of integrins and a serine protease (SP) domain that is in inactive conformation. The structure of the C3bBb complex would be important in deciphering the activation mechanism of the SP domain. However, C3bBb is labile and not amenable to X-ray diffraction studies. We engineered a disulfide bond in the vWFA domain of Bb homologous to that shown to lock I domains in active conformation. The crystal structures of Bb(C428-C435) and its inhibitor complexes reveal that the adoption of the "active" conformation by the vWFA domain is not sufficient to activate the C3-convertase catalytic apparatus and also provide insights into the possible mode of C3-convertase activation.

Disease

Known diseases associated with this structure: Macular degeneration, age-related, reduced risk of OMIM:[138470]

About this Structure

1RTK is a Single protein structure of sequence from Homo sapiens with , , and as ligands. Active as Alternative-complement-pathway C3/C5 convertase, with EC number 3.4.21.47 Full crystallographic information is available from OCA.

Reference

Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase., Ponnuraj K, Xu Y, Macon K, Moore D, Volanakis JE, Narayana SV, Mol Cell. 2004 Apr 9;14(1):17-28. PMID:15068800

Page seeded by OCA on Thu Feb 21 14:54:23 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools